Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular and Cellular Mechanisms of Action of Cannabidiol
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5980-5980
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

The renoprotective effects of cannabidiol on lipopolysaccharide-induced systemic inflammation model of rats
İlter İlhan, Halil Aşçı, Özlem Özmen, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 3
The Antioxidant and Neuroprotective Potential of Leaves and Inflorescences Extracts of Selected Hemp Varieties Obtained with scCO2
Anna Stasiłowicz-Krzemień, Szymon Sip, Piotr Szulc, et al.
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1827-1827
Open Access | Times Cited: 8
Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases
Nadia Martínez Naya, Jazmin Kelly, Austin C. Hogwood, et al.
Expert Opinion on Investigational Drugs (2024) Vol. 33, Iss. 7, pp. 699-712
Closed Access | Times Cited: 2
Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review
Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna, et al.
Veterinary Research Communications (2024) Vol. 48, Iss. 5, pp. 2915-2941
Open Access | Times Cited: 2
A Review of Sturge–Weber Syndrome Brain Involvement, Cannabidiol Treatment and Molecular Pathways
Katharine Elizabeth Joslyn, Nicholas Flinn Truver, Anne M. Comi
Molecules (2024) Vol. 29, Iss. 22, pp. 5279-5279
Open Access | Times Cited: 2
Assessing the Potential Synergistic/Antagonistic Effects of Citrinin and Cannabidiol on SH-SY5Y, HepG2, HEK293 Cell Lines, and Human Lymphocytes
Dubravka Rašić, Antonio Zandona, Maja Katalinić, et al.
Toxins (2024) Vol. 16, Iss. 12, pp. 534-534
Open Access | Times Cited: 1
Cannabis (THC) Aggravates the Deleterious Effects of Alcohol (EtOH) on Skeletal Muscles’ Mitochondrial Respiration: Modulation by Age and Metabolic Phenotypes
Anne‐Laure Charles, Margherita Giannini, Alain Meyer, et al.
Biology (2024) Vol. 13, Iss. 12, pp. 1080-1080
Open Access | Times Cited: 1
Cannabidiol in sports: insights on how CBD could improve performance and recovery
Daniel Rojas‐Valverde, Andrea Fallas-Campos
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Dual allosteric and orthosteric pharmacology of synthetic analog cannabidiol-dimethylheptyl, but not cannabidiol, on the cannabinoid CB2 receptor
Jara Bouma, Jeremy D. Broekhuis, Cas van der Horst, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115924-115924
Open Access | Times Cited: 4
Evaluating the Abuse Potential of Lenabasum, a Selective CB2 Cannabinoid Receptor Agonist
Rachel Luba, Gabriela Madera, Rebecca Schusterman, et al.
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 391, Iss. 2, pp. 272-278
Open Access | Times Cited: 1
FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis
Maheedhar Kodali, Leelavathi N. Madhu, Venkata Sai Vashishta Kolla, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Cannabis Use and Cannabidiol Modulate HIV-Induced Alterations in TREM2 Expression: Implications for Age-Related Neuropathogenesis
Bryant Avalos, Jacqueline R. Kulbe, Mary Ford, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1509-1509
Open Access | Times Cited: 1
Exploring Endocannabinoid System: Unveiling New Roles in Modulating ER Stress
Ilaria Capolupo, Maria Rosaria Miranda, Simona Musella, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1284-1284
Open Access | Times Cited: 1
Exploring the Potential of Nonpsychoactive Cannabinoids in the Development of Materials for Biomedical and Sports Applications
Dulexy Solano-Orrala, Dennis A. Silva-Cullishpuma, Eliana Díaz-Cruces, et al.
ACS Applied Bio Materials (2024)
Closed Access | Times Cited: 1
A eficácia do canabidiol no tratamento dos transtornos de ansiedade: Uma revisão integrativa de literatura
K. Rodrigues, L. S. NASCIMENTO, L. Coelho, et al.
Research Society and Development (2024) Vol. 13, Iss. 2, pp. e12213245015-e12213245015
Open Access
Cannabinoids and Postcardiac Surgery: Preclinical Insights Pave the Way for Future Research
Nadia Martínez Naya, Martin Denicolai, Jazmin Kelly, et al.
Journal of Cardiovascular Pharmacology (2024)
Open Access
Cannabis medicinal na gestão da dor crônica: Uma revisão de literatura narrativa
Hélen Assing, Julia Viana do Nascimento, Paulo André Bardini Lemos, et al.
Research Society and Development (2024) Vol. 13, Iss. 6, pp. e3113645994-e3113645994
Open Access
Historical perspective on the therapeutic potential of cannabidiol
Francisco Silveira Guimarães
International review of neurobiology (2024), pp. 1-9
Closed Access
Full‐spectrum cannabidiol reduces UVB damage through the inhibition of TGF‐β1 and the NLRP3 inflammasome
Ismael Manuel Urrutia‐Ortega, Israel Valencia, Octavio Ispanixtlahuatl-Meráz, et al.
Photochemistry and Photobiology (2024)
Open Access
Cannabidiol Alleviates Oral Mucositis by Inhibiting PI3K/Akt/NF-κB-Mediated Pyroptosis
Jialin Yang, Na Lin, Shuang Li, et al.
Balkan Medical Journal (2024), pp. 286-297
Open Access
Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials
Adriana Yndart, Kamila Vadell, Arti Vashist, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Effects of Cannabidiol (CBD) on Doxorubicin-Induced Anxiety and Depression-like Behaviors and mRNA Expression of Inflammatory Markers in Rats
Bristi Poudel, Brent M. Bany, Dale B. Hales, et al.
Brain Sciences (2024) Vol. 14, Iss. 10, pp. 999-999
Open Access
The Interplay of Exogenous Cannabinoid Use on Anandamide and 2-Arachidonoylglycerol in Anxiety: Results from a Quasi-Experimental Ad Libitum Study
Renée Martin‐Willett, Carillon J. Skrzynski, E. M. Taylor, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 10, pp. 1335-1335
Open Access
Cannabinoids and Genetic Epilepsy Models: A Review with Focus on CDKL5 Deficiency Disorder
Sean Massey, Anita Quigley, Simone Rochfort, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10768-10768
Open Access
The impact of cannabidiol placebo on amygdala-based neural responses to an acute stressor
Robin N Perry, Mikeala A Ethier-Gagnon, Carl Helmick, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 11, pp. 935-948
Open Access

Scroll to top